EBIT: Income before interest and taxes.
Advanced Medical Isotope Corporation (RDGL) had EBIT of $-1.10M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.02M |
|
$-1.08M |
|
$0.03M |
|
$-0.00M |
|
$1.12M |
|
$-1.10M |
|
$0.02M |
|
$-1.08M |
|
$-1.08M |
|
$-1.08M |
|
$-1.08M |
|
$-1.08M |
|
$-1.08M |
|
|
EBIT |
$-1.10M |
$-1.10M |
|
452.72M |
|
452.72M |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$1.65M |
|
$0.10M |
|
$0.22M |
|
$1.87M |
|
$0.12M |
|
-- |
|
$0.09M |
|
$0.21M |
|
$-7.69M |
|
$1.66M |
|
$1.66M |
|
455.49M |
|
| Cash Flow Statement Financials | |
$-2.06M |
|
$-0.10M |
|
$1.51M |
|
$2.21M |
|
$1.56M |
|
$-0.65M |
|
$1.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.54% |
|
-4426.79% |
|
-4426.79% |
|
-- |
|
-4357.28% |
|
-4357.28% |
|
$-2.16M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.49 |
|
1.11 |
|
81.20 |
|
14.03% |
|
-64.94% |
|
-57.75% |
|
-64.94% |
|
$0.00 |
|
$-0.00 |
|
$-0.00 |
|